Suchergebnisse - "Hoshida, Yujin"

PubPharm (6)

1

The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma : a phase 2 trial

enthalten in: Nature communications | 2024

von Hsiehchen, D. | Beg, M. | Kainthla, R. | +21

2

A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery

enthalten in: Nature communications | 2021

von Crouchet, E. | Bandiera, S. | Fujiwara, N. | +62

3

A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor

enthalten in: Nature communications | 2020

von Eller, C. | Heydmann, L. | Colpitts, C. | +20

4

A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor

sonderdruck aus: Nature communications | 2020

von Eller, C. | Heydmann, L. | Colpitts, C. | +20

5

Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of Yap

enthalten in: Nature communications | 2018

von Lee, Y. | Noon, L. | Akat, K. | +21

6

Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma

enthalten in: Nature communications | 2015

von Sia, D. | Losic, B. | Moeini, A. | +20

1
[1]